Fig. 5From: Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosisComparison of MP doses between the two groups. Compared with group C, the average dose of MP in group R was significantly reduced (P < 0.01). Abbreviations: MP, methylprednisolone; RUX, ruxolitinib; Group R, ruxolitinib-treated group; Group C, control group treated with conventional therapyBack to article page